USANA Health Sciences Executive Compensation Filing
Ticker: USNA · Form: DEF 14A · Filed: Apr 4, 2025 · CIK: 896264
| Field | Detail |
|---|---|
| Company | Usana Health Sciences Inc (USNA) |
| Form Type | DEF 14A |
| Filed Date | Apr 4, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-compensation, proxy-statement, equity-awards
TL;DR
USANA Health Sciences DEF 14A filed: exec comp details for FY24, equity awards for Brown & Guest.
AI Summary
USANA Health Sciences Inc. filed a DEF 14A on April 4, 2025, detailing executive compensation for the fiscal year ending December 28, 2024. The filing includes information on equity awards granted to individuals such as Mr. Brown and Mr. Guest, with details on the fair value of these awards and changes in their valuation.
Why It Matters
This filing provides transparency into how USANA Health Sciences compensates its top executives, which can influence investor decisions and perceptions of company management.
Risk Assessment
Risk Level: medium — DEF 14A filings related to executive compensation can sometimes reveal information that impacts stock price, especially if compensation structures are unusual or tied to performance metrics that are not being met.
Key Players & Entities
- USANA HEALTH SCIENCES INC (company) — Filer
- Mr. Brown (person) — Executive
- Mr. Guest (person) — Executive
- 2024-12-28 (date) — Fiscal Year End
- 20250404 (date) — Filing Date
FAQ
What is the total compensation reported for Mr. Brown for the fiscal year ending December 28, 2024?
The provided text does not contain specific dollar amounts for total compensation for Mr. Brown for the fiscal year ending December 28, 2024. It mentions equity awards and their fair values.
What was the fair value of equity awards granted to Mr. Guest in the fiscal year ending December 28, 2024?
The filing mentions Mr. Guest in relation to equity awards for the fiscal year ending December 28, 2024, but specific dollar amounts for the fair value of these grants are not detailed in the provided excerpt.
What is the primary purpose of a DEF 14A filing?
A DEF 14A filing is a Definitive Proxy Statement filed with the SEC, typically used to solicit shareholder votes on important corporate matters, including the election of directors and executive compensation.
When was USANA Health Sciences Inc. incorporated?
USANA Health Sciences Inc. was incorporated in Utah (UT).
What is the Standard Industrial Classification (SIC) code for USANA Health Sciences Inc.?
The SIC code for USANA Health Sciences Inc. is 2833, which corresponds to Medicinal Chemicals & Botanical Products.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 4, 2025 by Mr. Brown regarding USANA HEALTH SCIENCES INC (USNA).